This article was originally published on Psychedelic Spotlight and appears here with permission. Psychiatrists in the United States are increasingly warming up to the idea of treating patients with psychedelics.
This article was originally published on Psychedelic Spotlight and appears here with permission. Psychiatrists in the United States are increasingly warming up to the idea of treating patients with psychedelics.
Intravenous Ketamine Shows Promise for Treatment-Resistant Depression miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
1.
Saliva sampling could be a similarly sensitive, less costly alternative to nasal swabs for COVID-19 testing
Nasopharyngeal swabs are the primary sampling method used for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but they require a trained health care professional and extensive personal protective equipment. Saliva-based sampling for detecting SARS-CoV-2 has the potential to address many barriers associated with nasopharyngeal swabs. Authors from McGill University summarize evidence comparing the sensitivities for detection of SARS-CoV-2 infection between nasopharyngeal swabs and saliva samples. They found that saliva sampling to be a similarly sensitive and less costly alternative that could replace nasopharyngeal swabs for collection of clinical samples for SARS-CoV-2 testing.